Pinos Elisabet de los - 29 Oct 2025 Form 4 Insider Report for Aura Biosciences, Inc. (AURA)

Role
President and Chief Executive Officer, Director
Signature
/s/ Conor Kilroy, as Attorney-in-Fact
Issuer symbol
AURA
Transactions as of
29 Oct 2025
Net transactions value
-$57,461
Form type
4
Filing time
29 Oct 2025, 17:05:32 UTC
Previous filing
04 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
de los Pinos Elisabet President and Chief Executive Officer, Director C/O AURA BIOSCIENCES, INC., 80 GUEST STREET, BOSTON /s/ Conor Kilroy, as Attorney-in-Fact 29 Oct 2025 0001889633

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AURA Common Stock Sale $57,461 -9,049 -1.9% $6.35 474,391 29 Oct 2025 Direct F1
holding AURA Common Stock 127,763 29 Oct 2025 By EdIP Revocable Trust F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.
F2 The shares are held by the Elisabet de los Pinos Revocable Trust U/D/T dated April 8, 2016, of which the Reporting Person is a trustee.

Remarks:

President and Chief Executive Officer